| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE | 560 |
| 1 | ADALIMUMAB | 358 |
| 2 | DUPILUMAB | 356 |
| 3 | CLOZAPINE | 292 |
| 4 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 241 |
| 5 | HYDROMORPHONE HYDROCHLORIDE | 206 |
| 6 | MORPHINE SULFATE | 190 |
| 7 | FUROSEMIDE | 168 |
| 8 | PREDNISONE | 168 |
| 9 | ASPIRIN | 164 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 2 | 0.0278 |
| 1 | AMIVANTAMAB-VMJW | 40 | 0.0112 |
| 2 | ALMOTRIPTAN | 11 | 0.0104 |
| 3 | DIHYDROERGOTAMINE MESYLATE | 12 | 0.0089 |
| 4 | AMIKACIN SULFATE | 10 | 0.0057 |
| 5 | PEMIGATINIB | 4 | 0.0047 |
| 6 | SACITUZUMAB GOVITECAN | 21 | 0.0043 |
| 7 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 241 | 0.0043 |
| 8 | CEFUROXIME SODIUM | 5 | 0.0041 |
| 9 | BELANTAMAB MAFODOTIN | 12 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 513 |
| 1 | Atypical Antipsychotic [EPC] | 454 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 400 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 356 |
| 4 | Benzodiazepine [EPC] | 308 |
| 5 | Kinase Inhibitor [EPC] | 268 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 225 |
| 7 | Proton Pump Inhibitor [EPC] | 201 |
| 8 | Loop Diuretic [EPC] | 193 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 166 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 16 | 0.0233 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 7 | 0.0056 |
| 2 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 3 | Provitamin D2 Compound [EPC] | 111 | 0.0037 |
| 4 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 16 | 0.0027 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 7 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 2 | 0.0022 |
| 8 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 9 | Interleukin-17A Antagonist [EPC] | 64 | 0.0017 |